Annemarie Uhlig

<i>CTLA4</i> promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma

Niklas Klümper, Damian J. Ralser, Romina Zarbl et al. · Journal for ImmunoTherapy of Cancer · 2021 · 38 citations · Full text

Discriminating malignant and benign clinical T1 renal masses on computed tomography

Johannes Uhlig, Lorenz Biggemann, Manuel Nietert et al. · Medicine · 2020 · 37 citations · Full text

Radiomic Features and Machine Learning for the Discrimination of Renal Tumor Histological Subtypes: A Pragmatic Study Using Clinical-Routine Computed Tomography

Johannes Uhlig, Andreas Leha, Laura M. Delonge et al. · Cancers · 2020 · 37 citations · Full text

Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy

Annemarie Uhlig, Oliver Hahn, Joachim Lotz et al. · CardioVascular and Interventional Radiology · 2017 · 20 citations

Survival Benefit, Urology, Surgical Oncology +7

Understanding long-term continence rates after robot-assisted laparoscopic prostatectomy – one-year follow-up on “Cognitive ability as a non-modifiable risk factor for post-prostatectomy urinary incontinence”

Mathias Reichert, Hannah Maria Ploeger, Annemarie Uhlig et al. · Frontiers in Surgery · 2022 · 18 citations · Full text